Benzinga | Aug 6, 2021 08:06AM EDT

Meridian Bioscience Q3 Adj. EPS $0.22 Misses $0.31 Estimate, Sales $63.51M Miss $77.22M Estimate

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.31 by 29.03 percent. This is a 60 percent decrease over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $63.51 million which missed the analyst consensus estimate of $77.22 million by 17.75 percent. This is a 25.10 percent decrease over sales of $84.80 million the same period last year.